in a current german multicenter comparative study a minimum of 2 x 58 patients with active rheumatoid arthritis ( ra ) will be treated 36 weeks with sulfasalazine or aurothioglucose .
C0003873
rheumatoid arthritis
C0018033
aurothioglucose